Acadia Pharmaceuticals | Efectivo Y Equivalentes



Cash And Equivalent Cambio Fecha
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
ALKERMES USD 399.81M 108.66M 2025-03
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Biogen USD 2.6B 223.3M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Corcept Therapeutics USD 89.82M 37.85M 2025-03
Cytokinetics USD 938.22M 843.36M 2025-03
Eisai JPY 265.56B 25.7B 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Incyte USD 2.41B 720.83M 2025-03
J&J USD 38.47B 32.35B 2025-03
Moderna USD 1.62B 304M 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
Pfizer USD 1.43B 387M 2025-03
Prothena USD 471.39M 47.87M 2024-12
PTC Therapeutics USD 2.03B 1.25B 2025-03
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Ultragenyx Pharmaceutical USD 563M 389.27M 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Acadia Pharmaceuticals Efectivo Y Equivalentes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.